SPRY2 and breast cancer: Since decreased expression of tumor SPRY2 has been considered to be a significant independent prognostic factor and plays a cancer-promoting role in breast cancer [27], targeting SPRY2 might be a promising approach to achieve therapeutic effects in combating breast cancer.